Jackisch C, Anastasiadou L, Aulmann S, Argyriadis A, et al. The REMAR (Rhein-Main-Registry) real-world study: prospective evaluation of the 21-gene breast recurrence score(R) assay in addition to Ki-67 for adjuvant treatment decisions in early-stage breast cancer. Breast Cancer Res Treat 2024 Jun 14. doi: 10.1007/s10549-024-07390.
PMID: 38874685